Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial

  1. Winston, A.
  2. Post, F.A.
  3. DeJesus, E.
  4. Podzamczer, D.
  5. Di Perri, G.
  6. Estrada, V.
  7. Raffi, F.
  8. Ruane, P.
  9. Peyrani, P.
  10. Crofoot, G.
  11. Mallon, P.W.G.
  12. Castelli, F.
  13. Yan, M.
  14. Cox, S.
  15. Das, M.
  16. Cheng, A.
  17. Rhee, M.S.
Journal:
The Lancet HIV

ISSN: 2352-3018

Year of publication: 2018

Volume: 5

Issue: 4

Pages: e162-e171

Type: Article

DOI: 10.1016/S2352-3018(18)30010-9 GOOGLE SCHOLAR